Suffolk Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
2018
Q2
$691K Hold
2018
Q1
$775K Buy
2017
Q4
$846K Sell
2017
Q3
$1.46M Sell
2017
Q2
$1.85M Sell
2017
Q1
$1.74M Sell
2016
Q4
$1.89M Hold
2016
Q3
$1.48M Sell
2016
Q2
$2.16M Buy
2016
Q1
$1.68M Buy
2015
Q4
$1.64M Buy